BiotechTube
Home/Verastem Oncology/Dan Calkins
DC

Dan Calkins

Chief Financial Officer

Verastem Oncology

Therapeutic Areas

OncologyRAS/MAPK Pathway-Driven Cancers

Verastem Oncology Pipeline

DrugIndicationPhase
Avutometinib + DefactinibKRAS-mutant recurrent Low-Grade Serous Ovarian Cancer (LGSOC)Approved
Avutometinib + SotorasibKRAS G12C-mutant NSCLCPhase 1/2
Avutometinib + AdagrasibKRAS G12C-mutant NSCLCPhase 1/2

Leadership Team at Verastem Oncology

DP
Dan Paterson
President and Chief Executive Officer
CC
Cathy Carew
Chief Organizational Effectiveness Officer
FS
Faye Seyedi
Head of Chemistry, Manufacturing and Controls
View full Verastem Oncology profile